You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prostate-specific antigen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

dapted Strategy Including Magnetic Resonance Imaging and

Completed
  • Prostate Cancer
  • Prostate Adenocarcinoma
    • Ankara, Turkey
      Ankara University School of Medicine
    Sep 6, 2023

    Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA

    Recruiting
    • Prostatic Neoplasms
    • Radical prostatectomy (RP)
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Jul 14, 2023

    Prostate Cancer, Prostate Inflammation, PSA Trial in Albany (Ibuprofen or Naproxen, PSA test)

    Recruiting
    • Prostate Cancer
    • +2 more
    • Ibuprofen or Naproxen
    • PSA test
    • Albany, New York
      Albany Medical Center
    Nov 29, 2022

    PSA Trial in Chicago (Ibuprofen 400 mg)

    Active, not recruiting
    • PSA
    • Ibuprofen 400 mg
    • Chicago, Illinois
      University of Chicago
    Aug 21, 2022

    Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Columbus (Arm I Soy Bread, Arm II Soy-Almond Bread)

    Active, not recruiting
    • Recurrent Prostate Cancer
    • Stage IV Prostate Cancer
    • Arm I Soy Bread
    • Arm II Soy-Almond Bread
    • Columbus, Ohio
      The Ohio State University Medical Center
    Apr 29, 2022

    PSA, Prostate Cancer Trial in Chicago (Completing surveys)

    Active, not recruiting
    • PSA
    • Prostate Cancer
    • Completing surveys
    • Chicago, Illinois
      Mile Square Health Center
    Jul 14, 2022

    Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

    Recruiting
    • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
    • PSMA radionuclide therapy
    • Dallas, Texas
      Methodist Dallas Medical Center
    Aug 9, 2023

    Androgenetic Alopecia Trial (MK0906, finasteride / Duration of Treatment : 48 Weeks, Comparator : (unspecified) / Duration of

    Completed
    • Androgenetic Alopecia
    • MK0906, finasteride / Duration of Treatment : 48 Weeks
    • Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks
    • (no location specified)
    Feb 7, 2022

    Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

    Not yet recruiting
    • Prostate Adenocarcinoma
    • +2 more
    • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
    • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 4, 2023

    Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

    Available
    • Castration-Resistant Prostatic Cancer
    • (no location specified)
    Sep 11, 2023

    Prostate Cancer Trial in Tomsk (Whole body study and SPECT with [99mTc]Tc-BQ0413)

    Enrolling by invitation
    • Prostate Cancer
    • Whole body study and SPECT with [99mTc]Tc-BQ0413
    • Tomsk, Russian Federation
      TomskNRMC
    Oct 26, 2023

    Prostate Cancer Trial in Los Angeles (Intervention Session, Printed Material)

    Active, not recruiting
    • Prostate Cancer
    • Intervention Session
    • Printed Material
    • Los Angeles, California
      UCLA, Division of Cancer Prevention and Control Research
    Jul 1, 2022

    Prostate Cancer Trial in United States (PSMA-PET CT)

    Not yet recruiting
    • Prostate Cancer
    • PSMA-PET CT
    • Los Angeles, California
    • +3 more
    Jul 6, 2023

    Prostate Cancer Trial (Darolutamide Oral Tablet [Nubeqa])

    Not yet recruiting
    • Prostate Cancer
    • Darolutamide Oral Tablet [Nubeqa]
    • (no location specified)
    Jun 2, 2023

    Prostate Cancer Trial in Leuven (68Ga-PSMA (HBED-CC) PET)

    Recruiting
    • Prostate Cancer
    • 68Ga-PSMA (HBED-CC) PET
    • Leuven, Belgium
      UZLeuven
    Nov 18, 2022

    Prostate Cancer, Prostate Cancer Recurrent Trial in Mineola (Metformin Hydrochloride Extended Release 750mg)

    Completed
    • Prostate Cancer
    • Prostate Cancer Recurrent
    • Metformin Hydrochloride Extended Release 750mg
    • Mineola, New York
      Winthrop University Hospital
    Feb 2, 2022

    Prostate Disease, Elevated Prostate Specific Antigen, Family History of Prostate Cancer Trial in Lake Success, New York

    Recruiting
    • Prostate Disease
    • +4 more
    • Prostate Biopsy
    • +2 more
    • Lake Success, New York
    • +2 more
    Jan 27, 2023

    Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))

    Active, not recruiting
    • Prostate Cancer
    • +5 more
    • 131I-PSMA-1095 Radioligand Therapy (RLT)
    • Montreal, Quebec, Canada
      Stephan Probst
    Oct 24, 2022

    Prostate Cancer Trial in Aurora, Fort Collins (Grape Seed Extract)

    Recruiting
    • Prostate Cancer
    • Grape Seed Extract
    • Aurora, Colorado
    • +1 more
    Aug 22, 2022

    Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

    Recruiting
    • Malignancy
    • Al18F-PSMA-BCH PET/CT
    • Beijing, Chaoyang, China
      National Cancer Center/Cancer Hospital,Chinese Academy of Medica
    Mar 7, 2023

    Covid19, Prostate Specific Antigen Trial in Ankara (PSA value)

    Recruiting
    • Covid19
    • Prostate Specific Antigen
    • PSA value
    • Ankara, Altindag, Turkey
      Omer Gokhan Doluoglu
    Aug 15, 2021

    Promoting Shared-decision Making in Opportunistic Screening for

    Not yet recruiting
    • Decision Making, Shared
    • +2 more
    • Mixed-method approach
    • (no location specified)
    May 16, 2022

    Positron Emission Radiomics With PSMA Radioligands on Newly

    Not yet recruiting
    • Prostate Cancer
    • Immunohistochemistry (IHC) analysis
    • (no location specified)
    Apr 6, 2023

    Prostate Specific Antigen Screening, Asymptomatic Bacteriuria, Type 2 Diabetes Trial in Chicago (EHR clinical decision support

    Completed
    • Prostate Specific Antigen Screening
    • +2 more
    • EHR clinical decision support nudges
    • Brief clinician education
    • Chicago, Illinois
      Northwestern Medicine
    Nov 22, 2022

    Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)

    Active, not recruiting
    • Prostate Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 28, 2022